Results 111 to 120 of about 18,522 (215)

Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins

Journal of Lipid Research, 1999
Stable isotope methodology was used to determine the kinetic behavior of apolipoprotein (apo) A-I within the triglyceride-rich lipoprotein (TRL) fraction and to compare TRL apoA-I kinetics with that of apoA-I in high density lipoprotein (HDL) and TRL ...
Wanda Vélez-Carrasco, Alice H. Lichtenstein, P. Hugh R. Barrett, Zhiyong Sun, Gregory G. Dolnikowski, Francine K. Welty, Ernst J. Schaefer   +6 more
doaj   +1 more source

Role of apolipoprotein A-I in cholesterol transfer between lipoproteins. Evidence for involvement of specific apoA-I domains.

The Journal of biological chemistry, 1995
A series of monoclonal antibodies against epitopes spanning different domains of apoA-I have been tested for their effects on unesterified cholesterol transfer between low density lipoprotein (LDL) and well-defined homogenous lipoproteins reconstituted with phosphatidylcholine, cholesterol, and apoA-I (LpA-I). Antibodies 2G11 (reacting between residues
Q H, Meng, J, Bergeron, D L, Sparks, Y L, Marcel   +3 more
openaire   +2 more sources

Presence and severity of WMLs according to apoA-I quartiles.

, 2014
Values are percentages of patients. As levels of apoA-I increased, the presence and severity of WMLs increased (P for trend
Min Cui (264735), Ming-Ming Yu (562923), Ling Li (38566), Ze-Gang Yin (562921), Hua-Dong Zhou (562924), Shi-Ming Zhou (562922)   +5 more
core   +1 more source

Cloning and Characterization of a Novel Apolipoprotein A-I Binding Protein, AI-BP, Secreted by Cells of the Kidney Proximal Tubules in Response to HDL or ApoA-I

, 2002
Apolipoprotein A-I (apoA-I) is the major apolipoprotein of high-density lipoproteins (HDL) and has an important role in the regulation of the stability, lipid transport, and metabolism of HDL particles. To identify novel proteins that are involved in HDL
Orsó, Evelyn, Barlage, Stefan, Baehr, Carsten H, Fricker, Gert, Boettcher, Alfred, Schmiedeknecht, Gerno, Schmitz, Gerd, Ritter, Mirko, Bared, Salim Maa, Buechler, Christa, Schmitz-Madry, Anna   +10 more
core   +1 more source

Differential distribution of plasma apoA-I and apoB levels and clinical significance of apoB/apoA-I ratio in ischemic stroke subtypes

Frontiers in Neurology
Background and purposeIschemic stroke (IS) is classified into clinical subtypes and likely influenced by various lipid components. Nevertheless, the roles of apolipoprotein A-I (apoA-I), apolipoprotein B (apoB), and apoB/apoA-I ratio in different IS ...
Nguyen Van Tuyen, Nguyen Van Tuyen, Nguyen Hoang Ngoc, Phan Quoc Hoan, Nguyen Thi Yen, Nghiem Xuan Hoan, Nghiem Xuan Hoan, Nguyen Cam Thach   +7 more
doaj   +1 more source

β3-Adrenoceptor activation upregulates apolipoprotein A-I expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam cells

, 2017
Xia-qing Gao,1,2 Yan-fang Li,1,2 Zhi-li Jiang1,2 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 2Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, People’s Republic of China Objective: The aim ...
Gao XQ, Li YF, Jiang ZL
core  

Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients.

, 2007
BACKGROUND: The outcome of percutaneous coronary intervention (PCI) is apparently worse in patients receiving a prior thrombolytic therapy ('facilitated PCI').
Mombelli, G, B. Brusoni, G. Mombelli, L. Calabresi, Calabresi, L, Breghi, L, C.R. Sirtori, S. Klugmann, Wait, R, Gianazza, E, Wait, Robin, Sirtori, CR, E. Gianazza, I. Eberini, R. Wait, Klugmann, S, Brusoni, B, L. Breghi, M. Gomaraschi, Eberini, I, Gomaraschi, M   +20 more
core   +1 more source

Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring CholesterolEsterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo. CO-FIRST AUTHOR [PDF]

, 2012
The acute-phase protein haptoglobin (Hpt) binds apolipoprotein A-I (ApoA-I) and impairs its action on lecithin-cholesterol acyltransferase, an enzyme that plays a key role in reverse cholesterol transport. We have previously shown that an ApoA-I mimetic peptide, P2a, displaces Hpt from ApoA-I, restoring the enzyme activity in vitro.
BUCCI, MARIAROSARIA, CIGLIANO, LUISA, VELLECCO, VALENTINA, D'Andrea LD, Ziaco B, ROSSI, ANTONIETTA, SAUTEBIN, LIDIA, Carlucci A, ABRESCIA, PAOLO, PEDONE, CARLO, IANARO, ANGELA, CIRINO, GIUSEPPE   +11 more
openaire   +1 more source

Autoantibodies to apolipoprotein A-I in hepatitis C virus infection : a role in disease progression? [PDF]

Background: Chronic HCV (CHC) infection is associated with autoimmunity. IgG autoantibodies to apolipoprotein A-I (AAA-I) predict all-cause mortality. We evaluated AAA-I in CHC patients and in those who were not viraemic, either because of spontaneous ...
Cramp, M.E., Cramp, Matthew, Taylor-Robinson, Simon D., Neely, R Dermot, Shawa, Isaac T, Pagano, S., Cramp, Matthew E., Lodge, John K., Bridge, S.H., Pagano, Sabrina, Shawa, Isaac T., Lodge, John K, Neely, R Dermot G, Bridge, Simon H., Neely, R.D.G., Sheridan, David A, Sheridan, David A., Bridge, Simon H, Cramp, Matthew E, Taylor-Robinson, S.D., Marin-Crespo, Paula, Crespo, P.M, Bassendine, M.F., Vuilleumier, Nicolas, Shawa, I., Taylor-Robinson, Simon D, Bassendine, Margaret F, Neely, R. Dermot G., Sheridan, D.A., Vuilleumier, N., Bassendine, Margaret F., Lodge, J.K.   +31 more
core   +1 more source

The Level of Apolipoprotein A-I Is Associated with a Prognosis in Patients with Chronic Heart Failure Especially in HFmrEF and HFpEF: A Retrospective Cohort Study

XueChun He,1,* FaPeng Li,2,* Jian Zhang,1 ZhiYing Wen,1 YanXiao Li,3 WeiTong Gao,1 HongXia Chen,1 YangGuang Yu,1 YingYing Zheng,1 Xiang Xie1 1Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi ...
Li Y, Zheng Y, Wen Z, Zhang J, Xie X, He X, Li F, Gao W, Chen H, Yu Y   +9 more
core